what is microdose glp-1 microdosing for weight loss safe and effective? THE PCCA BLOG | Microdosing
Description
Semaglutide side effects are primarily gastrointestinal (nausea, digestive issues)
Kuwata H, Yabe D, Murotani K, Fujiwara Y, Haraguchi T, Kubota S, et al
Due to its sizable patient population with obesity and associated disorders such as type 2 diabetes and cardiovascular diseases, the United States in particular holds a significant portion of the market
Building a sustainable post-GLP-1 lifestyle The people who successfully maintain their weight after stopping GLP-1 medications share common characteristics
Triplehormone-receptor agonist retatrutide for obesity A phase 2 trial
Some need more aggressive interventions to improve metabolic health
